Dutasteride

For men seeking advanced treatment for androgenetic alopecia (AGA), dutasteride is an evidence-based and increasingly prescribed option. Although the FDA has approved it only for benign prostatic hyperplasia (BPH), strong clinical research supports its use for hair loss.
Dermatologists often recommend it off-label for men who haven’t responded to finasteride or who need more potent DHT suppression.
Male pattern hair loss (androgenetic alopecia) affects up to 80% of men at some point in their lives. Beyond its physical effects, it can impact confidence and overall quality of life. Among modern treatments, dutasteride has gained attention for its long-term efficacy and DHT-blocking potency.
This article provides a detailed overview of dutasteride, how it works compared to finasteride, what research shows about its effectiveness, recommended dosing, safety profile, and why it’s increasingly prescribed for androgenetic alopecia.
Dutasteride: Off-Label Option For AGA

Dutasteride is widely recognized as an effective off-label treatment for male pattern hair loss. Initially approved for treating an enlarged prostate, its strong DHT-blocking capability makes it a trusted choice for androgenetic alopecia. Off-label prescribing is a common, evidence-based practice in which clinicians use medications supported by data beyond their original indication.
Why Dutasteride Isn’t FDA-Approved For Hair Loss (Yet)
While dutasteride is FDA-approved for benign prostatic hyperplasia (BPH), it has not been approved in the U.S. for hair loss due to the absence of large-scale trials for that specific indication. However, regulators in Japan, South Korea, and Taiwan have approved 0.5 mg daily for male pattern hair loss based on strong safety and efficacy data. The lack of U.S. approval reflects regulatory timelines, not a question of effectiveness
Why Some Dermatologists Prescribe It Anyway
The practice of prescribing medication "off-label" is a standard and essential part of modern medicine. Dermatologists and other physicians can use their professional judgment to prescribe a drug for an unapproved use if they determine it is medically appropriate for their patient. This decision is typically based on robust scientific evidence and clinical experience.
In the case of dutasteride for hair loss, a wealth of data from numerous studies supports its use. These studies consistently demonstrate a high efficacy of dutasteride, often showing it to be even more effective than finasteride, the FDA-approved oral medication for hair loss. For a dermatologist, this evidence provides a strong rationale for prescribing it.
Ultimately, dermatologists prescribe dutasteride because their goal is to provide the best possible outcome for their patients. When faced with aggressive hair loss or a patient who hasn't responded to finasteride, the superior DHT-blocking power of dutasteride makes it an invaluable tool in their clinical practice.
Key Difference Between BPH Approval And AGA Use
The primary difference between using dutasteride for benign prostatic hyperplasia (BPH) and for androgenetic alopecia (AGA) lies in the condition being treated, not the drug's fundamental mechanism. In both cases, the effects of dutasteride are driven by its ability to dramatically reduce levels of dihydrotestosterone (DHT).
For BPH, the goal is to shrink an enlarged prostate gland. DHT is a key hormone that contributes to prostate growth, so lowering its levels helps reduce the symptoms of BPH. For AGA, the goal is to stop hair follicles from shrinking. DHT also binds to receptors in scalp follicles, causing the miniaturization that leads to pattern baldness..
So, while the drug administration targets different outcomes,prostate health versus hair restoration,the underlying action is the same. The dosage is also often identical, with 0.5 mg daily being a standard dose for both conditions. The key distinction is the "indication," or the specific medical reason for which the drug is prescribed.
How It Works vs Finasteride

Both dutasteride and finasteride belong to a class of drugs called 5-alpha reductase inhibitors, but they don't work in exactly the same way. The 5-alpha reductase enzyme is responsible for converting testosterone into dihydrotestosterone (DHT), the primary hormone behind male pattern hair loss. Finasteride primarily blocks one type of this enzyme, Type II.
Dutasteride, however, is a dual alpha reductase inhibitor, meaning it blocks both Type I and Type II enzymes. This broader action allows it to suppress the levels of DHT in the body much more significantly than finasteride. We'll now explore what this dual inhibition means for its potency and how each drug affects hormone pathways.
Dual 5α-Reductase Inhibition Explained (Type I & II)
To understand why dutasteride is so potent, it's helpful to know about the enzyme it targets: 5-alpha reductase. This enzyme comes in different forms, known as isozymes, which are found in various tissues throughout the body. The two most important types involved in androgenic processes are Type I and Type II.
Both isozymes are responsible for the conversion of testosterone into the more powerful androgen, DHT. However, they are distributed differently. The Type II enzyme is primarily found in hair follicles and the prostate, which is why blocking it is so effective for treating hair loss.
Here is how finasteride and dutasteride differ in their action:
-
Type II 5α-reductase: This is the primary target of finasteride. By inhibiting this isozyme, finasteride significantly reduces DHT levels.
-
Type I 5α-reductase: This isozyme is also present in the scalp and sebaceous glands. Dutasteride inhibits this type in addition to Type II.
-
Dutasteride's dual action: By blocking both isozymes, dutasteride provides a more thorough suppression of DHT production throughout the body.
Potency Comparison: Finasteride vs Dutasteride
The difference in how dutasteride and finasteride inhibit the 5-alpha reductase enzyme directly translates to a difference in potency. Because dutasteride blocks both Type I and Type II isozymes, it is significantly more powerful at reducing DHT levels in the bloodstream.
This increased potency is a key reason for the superiority of dutasteride in treating hair loss, as noted in several clinical studies. A more substantial reduction in DHT means less of the hormone is available to shrink hair follicles, which can lead to better outcomes in terms of hair regrowth and increased hair density.
The numbers clearly illustrate this difference in potency:
-
Dutasteride: A standard 0.5 mg daily dose can lower serum DHT levels by more than 90%.
-
Finasteride: A standard 1 mg daily dose lowers serum DHT levels by approximately 70%.
This 20% difference in DHT suppression can have a meaningful impact on treatment results, especially for men with more aggressive hair loss.
Which Hormone Pathways Each Drug Blocks
The primary hormone pathway that both dutasteride and finasteride influence is the conversion of testosterone to dihydrotestosterone (DHT). This process is a normal part of male physiology, but in people with androgenetic alopecia, hair follicles are genetically sensitive to DHT's effects. When DHT binds to androgen receptors in these follicles, it triggers miniaturization, causing hairs to become shorter and thinner until they eventually stop growing.
Both medications interrupt this pathway by inhibiting the 5-alpha reductase enzyme that facilitates it. By doing so, they drastically lower the amount of DHT circulating in the body and present in the scalp tissue. This reduces the androgenic signal that tells hair follicles to shrink.
Finasteride treatment primarily blocks the pathway mediated by the Type II enzyme. Dutasteride blocks the pathways mediated by both Type I and Type II enzymes. This broader blockade leads to lower overall DHT levels, offering a more powerful intervention against the hormonal trigger of male pattern hair loss.
What Studies Show
When considering any treatment, it’s essential to examine the scientific evidence. Numerous clinical trials have been conducted to evaluate the efficacy of dutasteride, especially in comparison to finasteride and placebo. These studies, ranging from smaller trials to large-scale systematic reviews, consistently paint a clear picture of dutasteride as a highly effective medication for male pattern hair loss.
The data from these studies often highlight not just its effectiveness, but its superiority over finasteride in key metrics like hair count and hair thickness. Let’s take a closer look at some specific findings from clinical trials in Asia, global meta-analyses, and long-term outcome studies.
Evidence From Japanese & Korean Clinical Trials
Since dutasteride is approved for the treatment of male AGA in several Asian countries, some of the most compelling evidence comes from clinical trials conducted in Japan and South Korea. These studies were crucial for gaining regulatory approval in those regions and provide strong support for its off-label use elsewhere.
For example, one randomized, placebo-controlled study in South Korea involved 153 men with AGA. The results showed that a daily 0.5 mg dose of dutasteride led to significantly higher hair counts and better hair growth assessments compared to placebo over six months. Another study in Japan followed 110 men for 52 weeks and concluded that dutasteride 0.5 mg daily demonstrated clear efficacy for improving hair growth and appearance.
These trials, which included a significant number of patients, confirm the efficacy of dutasteride in a real-world clinical setting.
|
Study Location |
Number of Patients |
Key Finding |
|
South Korea |
153 men |
Dutasteride 0.5 mg showed higher efficacy in hair counts compared to placebo after 6 months. |
|
Japan |
110 men |
Dutasteride 0.5 mg improved hair growth and global appearance over 52 weeks of treatment. |
Global Meta-Analyses Comparing Dutasteride To Finasteride
Beyond individual trials, meta-analyses offer an even higher level of evidence by pooling data from multiple studies. A 2019 systematic review and meta-analysis did just that, comparing the efficacy and safety of dutasteride and finasteride for treating men with androgenetic alopecia. This review combined the results of three studies involving over 900 men.
The findings from this large-scale analysis confirmed what many smaller studies had suggested: dutasteride is more effective than finasteride. The researchers noted that while both drugs were effective, dutasteride provided a statistically significant advantage in improving hair growth.
The key conclusions from the meta-analysis include:
-
Superior Hair Count: Dutasteride led to a greater increase in total hair count compared to finasteride at 24 weeks.
-
Improved Hair Thickness: Patients in the dutasteride treatment groups also experienced greater improvements in hair thickness.
-
Better Efficacy: The overall conclusion was that dutasteride "seems to provide a better efficacy compared with finasteride."
Long-Term Hair Density Outcomes
For a chronic condition like hair loss, long-term effectiveness is just as important as initial results. Studies have shown that both dutasteride and finasteride maintain their effectiveness over many years of continuous use, preventing further hair loss and sustaining hair regrowth.
A 2024 study on Korean men demonstrated that dutasteride 0.5 mg had sustained efficacy over five years, showing clinical improvement in hair density and thickness. Similarly, a 10-year study on finasteride in Japanese men found that 91.5% experienced improvement in hair growth over the decade. These findings indicate that 5-ARIs are a viable long-term solution.
For dutasteride specifically, studies measuring hair count and hair density show a significant improvement that continues to build over the first one to two years and is then maintained. This means you can expect not only to stop the progression of hair loss but also to see a lasting increase in hair density with consistent treatment.
Dosing & Timelines

Understanding the correct drug administration and what to expect over time is key to a successful treatment journey. For hair loss, dutasteride is typically prescribed as a daily oral medication. The most common dosage used in clinical trials and off-label practice is 0.5 mg per day.
Patience is essential, as hair growth is a slow process. Results are not immediate and build gradually over several months to years. The following sections will detail the typical dosing schedule, what you can expect to see in the first few months, and when you're likely to experience peak results.
Typical Off-Label Dosing For Men With AGA
When prescribed off-label for male androgenetic alopecia (AGA), the standard dose of dutasteride is almost universally 0.5 mg, taken as an oral capsule once daily. This is the same dosage approved for treating an enlarged prostate and is the dose that has been most extensively studied for its effects on hair loss.
Clinical trials comparing different doses of dutasteride, ranging from 0.02 mg to 2.5 mg, found that 0.5 mg provided the best balance of efficacy and safety. A randomized controlled study involving 917 men confirmed that the 0.5 mg dose significantly increased hair count compared to both finasteride and placebo at 24 weeks.
This dosage is also consistent with what has been approved for treating male AGA in other countries.
-
Standard Off-Label Dose: 0.5 mg oral dutasteride taken once per day.
-
Evidence-Based: This dose has been validated in numerous large-scale clinical trials and is the approved dose for hair loss in Japan and South Korea.
What To Expect In The First 3–6 Months
Starting a new hair loss treatment requires patience, as visible changes take time. In the first three to six months of taking dutasteride, your body is adjusting to the lower DHT levels. Some men may even experience a temporary period of shedding in the first few weeks as hair follicles reset their growth cycles. This is often a sign the medication is working.
By the six-month mark, many users begin to see the first signs of improvement. Clinical studies often use 24 weeks (six months) as a primary endpoint for measuring results. At this stage, you may notice a reduction in hair fall and the beginning of new hair growth.
Here's a general timeline for the initial phase:
-
First 3 Months: Hair loss should start to stabilize. Don't be discouraged by initial shedding, as this is normal for many.
-
Months 3 to 6: You may begin to see noticeable improvements in hair count and a reduction in thinning areas. Studies show a significant increase in hair growth by this point.
When Results Tend To Peak (12–24 Months)
While initial progress is often visible within six months, the full effects of dutasteride on hair regrowth and density typically take longer to manifest. The hair growth cycle is a slow process, and it takes time for miniaturized follicles to recover and produce thicker, longer hairs. Most users find that their results continue to improve well past the first year.
Peak improvement is generally observed between 12 and 24 months of consistent daily use. At this point, you will likely see the maximum increase in hair density and thickness. Long-term studies on the efficacy of dutasteride confirm that these results are sustained as long as the medication is taken.
Keep these points in mind for your long-term expectations:
-
Peak Results: Expect to see the most significant improvements in hair density between one and two years of starting treatment.
-
Maintenance is Key: Dutasteride is not a cure. Continuous use is required to maintain the results and prevent hair loss from resuming.
Side Effects & Monitoring

A responsible approach to any medication involves understanding its potential side effects. The safety of dutasteride has been evaluated in many large studies, and while it is generally well-tolerated, adverse events can occur. The most commonly discussed concerns relate to sexual dysfunction, but other effects are also possible.
It's important to remember that these side effects are uncommon and often resolve on their own. The following sections provide a balanced overview of what studies report about sexual side effects, other potential changes, and the recommended monitoring to ensure your health and quality of life.
Sexual Side Effects - What Studies Actually Report
Concerns about sexual side effects are common for anyone considering a 5-alpha reductase inhibitor. It's crucial to look at what the research actually says. Studies comparing dutasteride and finasteride have found that both have a similar incidence of adverse sexual effects, which are generally uncommon and often temporary.
A large meta-analysis found that while there was an increased risk of sexual dysfunction for men taking these drugs for BPH (an older population), the risk was not significantly increased for men being treated for AGA. Another systematic review concluded that many reported sexual adverse effects resolve spontaneously even with continued treatment.
The most commonly reported sexual side effects in clinical trials include:
-
Erectile dysfunction (impotence)
-
Decreased libido (low sex drive)
-
Ejaculation problems (e.g., decreased volume)
These events typically occur in a small percentage of users and their incidence decreases over time.
Mood, Fertility, And Hormone Changes
Beyond sexual function, some other potential adverse effects have been associated with dutasteride. Though rare, some users have reported mood changes, including depressive symptoms or anxiety. It is important to discuss any history of mental health conditions with your doctor before starting treatment.
The medication can also impact fertility. Studies show that 5-ARIs may have a negative effect on sperm parameters, such as sperm count, volume, and motility. However, for most men, these changes are not clinically significant and are reversible upon discontinuing the medication. If you are trying to conceive, this is a critical point to discuss with your provider.
As for hormone changes, altering hormones is the intended mechanism of dutasteride. By lowering DHT, it helps hair regrowth. This is the primary and desired effect on your hormonal balance.
Recommended Follow-Up Labs And Check-Ins
Safe and effective treatment with dutasteride requires ongoing communication with your healthcare provider. Regular check-ins allow your doctor to monitor your progress, assess for any adverse effects, and make any necessary adjustments to your treatment plan.
One important consideration for monitoring is its effect on prostate-specific antigen (PSA) levels, a marker used in screening for prostate cancer. Dutasteride can lower PSA levels, which is important for any doctor to know if you are undergoing prostate cancer screening. You should always inform all of your healthcare providers that you are taking this medication.
Here are key recommendations for follow-up:
-
Regular Doctor Visits: Schedule follow-up appointments to discuss your response to the treatment and report any side effects you may be experiencing.
-
Inform Your Providers: Make sure your primary care physician and any other specialists are aware you are on dutasteride, especially for PSA testing.
Who Might (And Might Not) Consider It
Is dutasteride the right choice for you? The decision is a personal one that should be made with a healthcare professional. In clinical practice, dutasteride is often considered for specific types of patients with male androgenic alopecia. Generally, it's an option for those seeking a more powerful treatment than finasteride or for those with very aggressive hair loss.
However, it is not suitable for everyone. Certain medical conditions and life circumstances make it a poor choice. The following sections will detail who might be an ideal candidate for dutasteride and, just as importantly, who should avoid it.
Men Who Don’t Respond To Finasteride
One of the most common reasons a doctor might suggest dutasteride is if a patient has already tried finasteride treatment without seeing the desired results. Some men are considered "non-responders" or "slow-responders" to finasteride, meaning their hair loss continues to progress despite treatment.
In these cases, dutasteride can be an excellent alternative treatment. A 2014 study specifically looked at the effect of dutasteride in men with androgenetic alopecia who were "recalcitrant to finasteride" and found it to be an effective option. Its superior potency in lowering DHT levels can be enough to overcome the limitations experienced with finasteride. Even lower doses of dutasteride have been shown to be effective.
Consider these points if finasteride hasn't worked for you:
-
A Powerful Next Step: Dutasteride's ability to block both types of 5-alpha reductase makes it a logical and potent alternative.
-
Greater Efficacy: The more significant DHT reduction offered by dutasteride may be what's needed to achieve stabilization and regrowth.
Candidates With Advanced Or Aggressive AGA
For men experiencing particularly advanced or aggressive hair loss, starting with a more potent treatment may be a strategic choice. Androgenetic alopecia that begins at a younger age often predicts a more severe form of the condition later in life. In these situations, quickly gaining control over DHT levels is critical to preserving hair.
Dutasteride's ability to reduce serum DHT by over 90% makes it a formidable tool for the treatment of male pattern hair loss that is progressing rapidly. By significantly halting the hormonal trigger, it can slow down even aggressive hair loss and provide a better chance for hair restoration.
If your hair loss is widespread or has advanced quickly, a discussion with your doctor about dutasteride as a first-line therapy might be warranted. Its powerful mechanism is well-suited to combatting the most challenging cases of AGA.
Who Should Avoid It (Liver Disease, Pregnancy Exposure Risk)
While dutasteride is effective, it is not safe for everyone. There are important contraindications and warnings to consider. The most critical involves the risk of pregnancy exposure. Dutasteride can cause serious birth defects in a developing male fetus. For this reason, women who are pregnant or may become pregnant should not handle the capsules.
Men taking dutasteride whose partners are or may become pregnant should use barrier contraception (condoms) during intercourse. The concentration of the drug in semen is low, but this precaution is recommended to eliminate any potential risk.
In addition to pregnancy risks, there are other restrictions to be aware of.
-
Pregnancy Exposure: Leaking capsules should not be handled by women who are or may become pregnant due to the risk of absorption through the skin and subsequent birth defects.
-
Blood Donation: Men taking dutasteride are not permitted to donate blood during treatment and for a period after stopping to prevent the drug from being transfused to a pregnant woman.
Ask A HealthOn Clinician About Next-Step Options
Making an informed decision about your hair loss treatment is the most important step you can take. Consulting with a qualified clinician at Healthon is essential to weigh the pros and cons of each option for your unique situation. A healthcare professional can assess your pattern of hair loss, review your medical history, and help you navigate the choices.
If you’re considering dutasteride, finasteride, or a combination of therapies, safe prescribing practices ensure you receive the most appropriate and effective treatment. Let’s explore how to decide between these medications and how a provider ensures your safety throughout the process.
Deciding Between Finasteride And Dutasteride
The choice between finasteride and dutasteride is a key treatment decision that you should make in partnership with your doctor. There is no single "best" answer for everyone, as the right choice depends on your specific pattern of hair loss, your treatment history, and your personal risk tolerance.
In clinical practice, finasteride is often considered the first-line oral treatment because it is FDA-approved for hair loss and has been used by millions of men for decades. Its efficacy and safety profile are extremely well-documented.
Dutasteride is typically reserved as a second-line option or for specific cases due to its off-label status and higher potency.
-
Finasteride First: Many doctors recommend starting with finasteride due to its official approval and extensive track record.
-
Consider Dutasteride If: You have not achieved satisfactory results with finasteride, or if you have particularly aggressive or advanced hair loss from the start.
When Combination Therapy Makes Sense
To maximize results, many men with male pattern baldness benefit from combination therapy. This approach involves using treatments that work through different mechanisms to attack hair loss from multiple angles. Combining an oral 5-ARI like dutasteride with a topical growth stimulant like minoxidil is a very common and highly effective strategy.
Dutasteride works systemically to lower DHT, tackling the root hormonal cause of the problem. Topical minoxidil, on the other hand, works directly on the scalp to increase blood flow to hair follicles and prolong the anagen (growth) phase of the hair cycle.
Here are two popular combination approaches:
-
Oral Dutasteride + Topical Minoxidil: This powerful duo combines DHT-blocking with direct growth stimulation for enhanced hair regrowth.
-
Topical Formulations: For those concerned about systemic side effects, topical dutasteride (often combined with minoxidil in a single formula) can be a great option. It targets the scalp directly with less absorption into the bloodstream.
How Healthon Ensures Safe Prescribing
A qualified provider prioritizes your safety above all else. The process of prescribing a medication like dutasteride involves more than just writing a prescription; it's a holistic approach to care that ensures the treatment is appropriate and well-monitored.
This begins with a thorough consultation. A provider will review your complete medical history, discuss your hair loss journey, and explain the potential risks and benefits of all treatment options. This informed consent process is crucial for making a decision you are comfortable with.
Safe prescribing is an ongoing partnership that includes:
-
A Comprehensive Medical Evaluation: Your provider will assess your overall health to ensure there are no contraindications before prescribing dutasteride.
-
Ongoing Monitoring and Follow-Up: Regular check-ins are essential to track your progress, manage any potential adverse effects, and make sure the treatment remains safe and effective for you over the long term.
Dutasteride offers a powerful, evidence-based option for men with androgenetic alopecia, particularly for those who haven’t achieved results with finasteride. By inhibiting both Type I and Type II 5-alpha-reductase, it provides greater DHT suppression and measurable hair regrowth. While it requires ongoing medical supervision, dutasteride can be a highly effective part of a clinician-guided treatment plan.
Frequently Asked Questions
Can I Switch From Finasteride To Dutasteride For Hair Loss?
Yes, switching from finasteride to dutasteride is a common strategy for men with male androgenetic alopecia who have not seen adequate results. Because dutasteride is more potent, it can be effective where finasteride was not. Always consult your doctor before making any changes to your treatment plan.
Is Dutasteride More Effective Than Finasteride?
Yes, multiple studies and meta-analyses have concluded that dutasteride is more effective than finasteride for treating androgenic alopecia. It reduces DHT levels more significantly, which often leads to greater improvements in hair count and hair density. This makes it a powerful option for many patients.
Can I Combine Dutasteride With Minoxidil?
Yes, combining oral dutasteride with topical minoxidil is a highly effective approach for treating male pattern baldness. Dutasteride blocks the hormone that causes hair loss, while minoxidil directly stimulates hair regrowth. This two-pronged strategy often leads to better results than using either treatment alone.
Will I Experience Shedding When Starting Dutasteride?
It is possible to experience a temporary increase in shedding when you first start taking dutasteride. This is typically a sign that the medication is working, as it pushes your hair follicles into a new growth phase. This initial shedding is usually short-lived and gives way to hair regrowth.
How Long Does It Take To See Results With Dutasteride?
You may start to see a reduction in hair loss within 3-6 months, but it typically takes 12-24 months to see the peak improvement in hair regrowth and density. Consistent daily use is essential to achieve a significant improvement in male AGA.
What Happens If I Stop Taking Dutasteride?
If you stop taking dutasteride, your DHT levels will return to their pre-treatment levels, and the hair loss process will likely resume. Any hair density gained during treatment will gradually be lost. Dutasteride is a long-term treatment that requires continuous use to maintain its effects on androgen receptors.
Is Topical Dutasteride Safer Than Oral?
Topical dutasteride is designed to minimize absorption into the bloodstream, which may lower the risk of systemic adverse effects compared to oral dutasteride. While research is ongoing, it's considered a promising option in clinical practice for those concerned about the safety profile of the oral medication.
Reference List
-
Dr. Hair. (2023). Dutasteride vs finasteride: Which works best for hair loss? https://drhair.co.uk/blog/dutasteride-vs-finasteride-which-works-best-for-hair-loss/
-
Global Medical Research. (2023). Finasteride and dutasteride for the treatment of male androgenetic alopecia: A review of efficacy and reproductive adverse effect. https://gmr.scholasticahq.com/article/88531-finasteride-and-dutasteride-for-the-treatment-of-male-androgenetic-alopecia-a-review-of-efficacy-and-reproductive-adverse-effect
-
International Society of Hair Restoration Surgery. (2023). Dutasteride for hair loss. https://ishrs.org/patients/treatments-for-hair-loss/medications/dutasteride/
-
National Center for Biotechnology Information. (2023). Dutasteride. In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK555930/
-
PubMed Central. (2024a). Dutasteride clinical efficacy in androgenetic alopecia. https://pmc.ncbi.nlm.nih.gov/articles/PMC11668469/
-
PubMed Central. (2024b). Long-term dutasteride outcomes in male hair loss. https://pmc.ncbi.nlm.nih.gov/articles/PMC11694415/
-
Cureus. (2024). Topical dutasteride clinical trial in androgenetic alopecia. https://www.cureus.com/articles/375228-a-randomized-double-blind-placebo-and-active-controlled-phase-ii-study-to-evaluate-the-safety-and-efficacy-of-novel-dutasteride-topical-solution-001-002-and-005-wv-in-male-subjects-with-androgenetic-alopecia
-
Translational Andrology and Urology. (2023). Mechanism and clinical insights into dutasteride use. https://tau.amegroups.org/article/view/111026/html
-
ForHims UK. (2023). Finasteride vs dutasteride: Which is better for preventing hair loss? https://www.forhims.co.uk/blog/finasteride-vs-dutasteride-which-is-better-for-preventing-hair-loss
-
Dr. Hair. (2023). Clinical differences between dutasteride and finasteride. https://drhair.co.uk/blog/dutasteride-vs-finasteride-which-works-best-for-hair-loss/
-
Global Medical Research. (2023). Systematic review of dutasteride vs finasteride. https://gmr.scholasticahq.com/article/88531-finasteride-and-dutasteride-for-the-treatment-of-male-androgenetic-alopecia-a-review-of-efficacy-and-reproductive-adverse-effect
-
ISHR. (2023). Patient information: Dutasteride for AGA. https://ishrs.org/patients/treatments-for-hair-loss/medications/dutasteride/
-
Tau. (2023). Dutasteride safety and sexual side effects. https://tau.amegroups.org/article/view/111026/html
-
Cureus. (2024). Topical dutasteride in clinical practice. https://www.cureus.com/articles/375228-a-randomized-double-blind-placebo-and-active-controlled-phase-ii-study-to-evaluate-the-safety-and-efficacy-of-novel-dutasteride-topical-solution-001-002-and-005-wv-in-male-subjects-with-androgenetic-alopecia
- PubMed Central. (2024c). Dutasteride real-world efficacy and safety studies. https://pmc.ncbi.nlm.nih.gov/articles/PMC11694415/








